Tumor malignancy and clinical prognosis correlates with vascular-rich features, which are characterized by vascular proliferation in response to abundant vascular endothelial growth factor (VEGF) produced by tumor cells [2, 3]. This evidence concerns the gene VEGFA and neoplasm.